When it can heal the brain injury, and the brain is floating in fatty acid, why not EPA would help the AD patients? I am betting big time on the BRAVE study. Cheers!
A positive Brave study would not only validate Vascepa as a treatment for Altzheimers...but it would also validate the concept that Vascepa's effectiveness is due to its anti-inflammatory qualities....This would further made the case for its use in other inflammatory diseases such as CVD etc.
Market Data 
Markets 
AI
